Giant Cell Arteritis

Researchers reveal that the benefit of intravenous glucocorticoid treatment in patients with giant cell arteritis may not be significant enough to risk exposure to the drugs’ toxicity.

While already common practice in Europe, the use of vascular ultrasound to diagnose giant cell arteritis has been limited in the United States. New research aims to change that.

Sharon Chung, MD, lead investigator on the new practice guideline for vasculitis, discussed how the guideline will help rheumatologists manage classic systemic vasculitis conditions they may encounter in...

Patients with large-vessel giant cell arteritis may see disease improvement when treated early with steroid-sparing agents, recent research reveals.

Patients with giant cell arteritis see long-term effects after 1 year of treatment with tocilizumab